A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
Berberine (BBR) has been reported that it has effects on inhibiting colorectal cancer (CRC). However, the mechanism of BBR on CRC also remains largely unknown. Herein, we investigated the therapeutic effects of BBR on CRC from the perspective of gut microbiota and metabolic alterations, which can pr...
Main Authors: | Haitao Chen, Fan Zhang, Jin Zhang, Xinjie Zhang, Yong Guo, Qinghua Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.588079/full |
Similar Items
-
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota
by: Haitao Chen, et al.
Published: (2022-05-01) -
Berberine: An inspiring resource for the treatment of colorectal diseases
by: Fang Cao, et al.
Published: (2023-11-01) -
Study on the protective effect of berberine treatment on sepsis based on gut microbiota and metabolomic analysis
by: Huibin Pan, et al.
Published: (2022-12-01) -
Metabolomics profiling reveals berberine-inhibited inflammatory response in human gingival fibroblasts by regulating the LPS-induced apoptosis signaling pathway
by: Ying Zhang, et al.
Published: (2022-08-01) -
Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
by: Xinchi Feng, et al.
Published: (2021-01-01)